Crystal Lederhos Smith1,2,3, Sara F Waters4, Danielle Spellacy1, Ekaterina Burduli2,3,5, Olivia Brooks1,2, Cara L Carty1, Samantha Ranjo5, Sterling McPherson1,2,3, Celestina Barbosa-Leiker3,5. 1. Elson S. Floyd College of Medicine, Washington State University, Spokane, WA, U.S.A. 2. Program of Excellence in Addictions Research, Washington State University, Spokane, WA, U.S.A. 3. Analytics and PsychoPharmacology Laboratory (APPL), Washington State University, Spokane, WA, U.S.A. 4. Department of Human Development, Washington State University, Vancouver, WA, U.S.A. 5. College of Nursing, Washington State University, Spokane, WA, U.S.A.
Abstract
Objectives: We examined the prevalence of substance use as a coping mechanism and identified relationships between maternal mental health over time and use of substances to cope during the Coronavirus Disease 2019 (COVID-19) pandemic among pregnant women in the U.S.A. Methods: Self-reported repeated measures from 83 pregnant women were collected online in April 2020 and May 2020. Women retrospectively reported their mental/emotional health before the pandemic, as well as depression, stress, and substance use as a result of the pandemic at both time points. Linear regression measured cross-sectional and longitudinal associations between mental health and substance use. Results: Pre-COVID-19 reports of poorer mental/emotional health (b = 0.46) were significantly (p < .05) associated with number of substances used to cope with the pandemic. Elevated stress (b = 0.35) and depressive symptoms (b = 0.27) and poorer mental/emotional health (b = 0.14) in April were also significantly related to higher numbers of substances used in May (p < .05). Conclusion: Pregnant women's psychological well-being may be a readily measured indicator substance use risk during crises such as the COVID-19 pandemic. Interventions addressing increased stress and depression may also mitigate the emergence of greater substance use among pregnant women .
Objectives: We examined the prevalence of substance use as a coping mechanism and identified relationships between maternal mental health over time and use of substances to cope during the Coronavirus Disease 2019 (COVID-19) pandemic among pregnant women in the U.S.A. Methods: Self-reported repeated measures from 83 pregnant women were collected online in April 2020 and May 2020. Women retrospectively reported their mental/emotional health before the pandemic, as well as depression, stress, and substance use as a result of the pandemic at both time points. Linear regression measured cross-sectional and longitudinal associations between mental health and substance use. Results: Pre-COVID-19 reports of poorer mental/emotional health (b = 0.46) were significantly (p < .05) associated with number of substances used to cope with the pandemic. Elevated stress (b = 0.35) and depressive symptoms (b = 0.27) and poorer mental/emotional health (b = 0.14) in April were also significantly related to higher numbers of substances used in May (p < .05). Conclusion: Pregnant women's psychological well-being may be a readily measured indicator substance use risk during crises such as the COVID-19 pandemic. Interventions addressing increased stress and depression may also mitigate the emergence of greater substance use among pregnant women .
Authors: Christine Rubertsson; Karin Börjesson; Anna Berglund; Ann Josefsson; Gunilla Sydsjö Journal: Nord J Psychiatry Date: 2011-07-05 Impact factor: 2.202
Authors: Pradip Dashraath; Jing Lin Jeslyn Wong; Mei Xian Karen Lim; Li Min Lim; Sarah Li; Arijit Biswas; Mahesh Choolani; Citra Mattar; Lin Lin Su Journal: Am J Obstet Gynecol Date: 2020-03-23 Impact factor: 8.661